Ads
related to: bristol-myers squibb- World-Class Products
Discover more about our FDA-
approved treatment options.
- Astellas Pharma Support
Learn about our Support Solutions
and find helpful enrollment forms.
- Patient Commitment
Our Patient Centricity Team aims to
change the course of cancer care.
- Science and Innovation
View our approach to finding
solutions for cancer's complexities
- World-Class Products
Search results
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Zacks via Yahoo Finance· 4 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
2 No-Brainer Dividend Stocks You Can Buy With $100 in June | The Motley Fool
The Motley Fool· 6 days agoSearching for investments that can outperform the benchmark S&P 500 index often gets wickedly...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 5 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company paid nearly $5 billion ...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters· 7 days ago, opens new tab immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer...
Fork Cancer fundraiser to bring delicious food, live music to Lunken Airport
Cincinnati.com | The Enquirer via Yahoo News· 5 days agoPartying for a good cause? Fork yeah! Fork Cancer, an inaugural event presented by global biopharmaceutical company Bristol Myers Squibb, is seeking to raise awareness and support for the American ...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoA month has gone by since the last earnings report for Prothena (PRTA). Shares have lost about 1.5%...
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Reuters via Yahoo News· 7 days agoThe study of 423 patients with stage 3 melanoma found that 83.7% of patients who received the...
Geron surges after winning first US FDA approval for blood disorder drug
Colorado Springs Gazette· 2 days agoThe health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes (MDS), a ...
Geron Stock Soars on FDA Approval of Drug for Patients With Rare Blood Cancers
Investopedia· 2 days agoGeron (GERN) shares skyrocketed over 19% in intraday trading Friday after the Food and Drug...
Geron surges after winning first US FDA approval for blood disorder drug
Reuters· 1 day ago, opens new tab surged more than 30% on Friday, a day after the company gained its first approval...